Literature DB >> 24619241

Smoking behavior characteristics of non-selected smokers with childhood attention-deficit/hyperactivity disorder (AD/HD) history: a systematic review and meta-analysis.

Guillaume Fond1, Anderson Loundou, Sebastien Guillaume, Xavier Quantin, Alexandra Macgregor, Régis Lopez, Philippe Courtet, Paquito Bernard, Daniel Bailly, Mocrane Abbar, Marion Leboyer, Laurent Boyer.   

Abstract

It is unclear whether adult smokers with childhood attention-deficit/hyperactivity disorder history (CH) have more severe smoking behavior than non-CH smokers, while it is clearly suggested that CH adolescents have more severe smoking behavior than CH adolescents. The aim of the present comprehensive meta-analysis is to determine whether CH smokers have more severe smoking behavior characteristics than those without and the effect of age on the association between CH and smoking behavior. We included all case-control studies and first round data collection of observational studies addressing the difference in smoking behavior characteristics of CH smokers versus non-CH smokers, with validated scales or structured interviews, without any language or date restriction. Nine studies (including 365 smokers with CH and 1,708 smokers without) were included. Compared to non-CH smokers, CH smokers smoked significantly more cigarettes [standardized mean differences (SMD) = 0.15, 95 % CI 0.01-0.28, p = 0.04] and began to regularly smoke earlier (SMD = -0.28, 95 % CI -0.49; -0.07, p = 0.01) but were not significantly more nicotine dependent (SMD = 0.23, 95 % CI -0.04 to 0.48, p = 0.08). After removing the single adolescent study, the significant association between CH and number of daily smoked cigarettes disappeared, and subgroups analyses confirmed that the significant association between CH and number of daily smoked cigarettes disappeared as age increased. Our meta-analysis illustrates a clinically important link between CH and tobacco smoking in adolescence but not later in life. Further high-quality studies are needed to confirm this finding, as only two studies included participants with a mean age below 20 years.

Entities:  

Mesh:

Year:  2014        PMID: 24619241      PMCID: PMC5103035          DOI: 10.1007/s00406-014-0497-5

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  44 in total

1.  ADHD as a serious risk factor for early smoking and nicotine dependence in adulthood.

Authors:  Swantje Matthies; Sebastian Holzner; Bernd Feige; Corinna Scheel; Evgeniy Perlov; Dieter Ebert; Ludger Tebartz van Elst; Alexandra Philipsen
Journal:  J Atten Disord       Date:  2012-01-27       Impact factor: 3.256

2.  Smoking trajectories of adolescent novice smokers in a longitudinal study of tobacco use.

Authors:  Igor Karp; Jennifer O'Loughlin; Gilles Paradis; James Hanley; Joseph Difranza
Journal:  Ann Epidemiol       Date:  2005-07       Impact factor: 3.797

Review 3.  Can we prevent smoking in children with ADHD: a review of the literature.

Authors:  Vania Modesto-Lowe; Jeffrey S Danforth; Carla Neering; Caroline Easton
Journal:  Conn Med       Date:  2010-04

4.  ADHD medication reduces cotinine levels and withdrawal in smokers with ADHD.

Authors:  Jean-G Gehricke; Nuong Hong; Timothy L Wigal; Vivien Chan; Ashley Doan
Journal:  Pharmacol Biochem Behav       Date:  2011-02-26       Impact factor: 3.533

5.  Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.

Authors:  Jonathan A C Sterne; Alex J Sutton; John P A Ioannidis; Norma Terrin; David R Jones; Joseph Lau; James Carpenter; Gerta Rücker; Roger M Harbord; Christopher H Schmid; Jennifer Tetzlaff; Jonathan J Deeks; Jaime Peters; Petra Macaskill; Guido Schwarzer; Sue Duval; Douglas G Altman; David Moher; Julian P T Higgins
Journal:  BMJ       Date:  2011-07-22

6.  [Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder].

Authors:  P Retz-Junginger; W Retz; D Blocher; R-D Stieglitz; T Georg; T Supprian; P H Wender; M Rösler
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

7.  The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

Authors:  M F Ward; P H Wender; F W Reimherr
Journal:  Am J Psychiatry       Date:  1993-06       Impact factor: 18.112

8.  Personality differences associated with smoking experimentation among adolescents with and without comorbid symptoms of ADHD.

Authors:  Kenneth P Tercyak; Janet Audrain-McGovern
Journal:  Subst Use Misuse       Date:  2003-12       Impact factor: 2.164

9.  Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study.

Authors:  F Joseph McClernon; Scott H Kollins; Avery M Lutz; David P Fitzgerald; Desiree W Murray; Christina Redman; Jed E Rose
Journal:  Psychopharmacology (Berl)       Date:  2007-11-25       Impact factor: 4.530

10.  Psychometric characteristics of the Wender Utah Rating Scale (WURS): reliability and factor structure for men and women.

Authors:  M A Stein; R Sandoval; E Szumowski; N Roizen; M A Reinecke; T A Blondis; Z Klein
Journal:  Psychopharmacol Bull       Date:  1995
View more
  3 in total

1.  Historical aspects of Mozart's mental health and diagnostic insights of ADHD and personality disorders.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08       Impact factor: 5.270

2.  Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study.

Authors:  Tor-Arne Hegvik; Johanne Telnes Instanes; Jan Haavik; Kari Klungsøyr; Anders Engeland
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-10-05       Impact factor: 4.785

3.  Minor physical anomalies in adolescents at risk for substance use and early sex.

Authors:  Meng-Che Tsai; Chih-Ting Lee; I-Ning Tsai; Shu-Ting Gan; Yi-Lin Liang; Sheng-Hsiang Lin
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.